Bioscience Equity Partners
Venture capitalDubai · Late Stage · 1 people tracked
Find your way into Bioscience Equity Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Catherine Pickering to introduce you to George Syrmalis
You →Catherine · together at Antisoma →George
Sign up to find every way you can get introduced to Bioscience Equity Partners
- Your email: who you already know at Bioscience Equity Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bioscience Equity Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Bioscience Equity Partners structures, anchors, and closes institutional capital transactions across two divisions. In life sciences, its affiliated anchor fund Antisoma Venture Capital anchors roughly half of each round for biotechnology, medical technology, and digital health companies, with the remainder syndicated across a consortium of sovereign and quasi-sovereign funds. Its Infrastructure & Sovereign Advisory division structures and executes infrastructure-grade transactions for governments, ministries, sovereign funds, and state-owned enterprises across energy, agricultural biotechnology, and defence-adjacent manufacturing. The firm runs every mandate from origination to close and engages only counterparties known to its consortium, declining unsolicited approaches.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does Bioscience Equity Partners invest at?
- Bioscience Equity Partners invests at the Late Stage stage.
- What sectors does Bioscience Equity Partners focus on?
- Bioscience Equity Partners focuses on Advanced Manufacturing, AgTech, Biotech, Defense Tech, Digital Health, Energy, Healthtech, Longevity, Medical Devices.
- Where is Bioscience Equity Partners located?
- Bioscience Equity Partners is headquartered in Dubai, AE.
Media · Podcasts & interviews
featuring the teamInside the Mind of a Global Biotech Investor: Dr. George Syrmalis, CEO, Bioscience Equity Partners
Analyzing Healthcare by SCALE Community · George Syrmalis
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.










